Investor advisory firms back Takeda's $62 billion deal for Shire

[ad_1]
Two shareholder advisory firms have backed Takeda Pharmaceutical’s $62 billion (48 billion pounds) takeover offer for drugmaker Shire , dealing a blow to a group of investors who hope to block the deal.

[ad_2]
Source link